id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-E-0397-0001,FDA,FDA-2013-E-0397,U.S. Patent and Trademark Office - Letter,Other,Letter(s),2013-04-05T04:00:00Z,2013,4,2013-04-05T04:00:00Z,,2013-04-05T14:24:27Z,,0,0,090000648126ddc9
FDA-2013-E-0397-0002,FDA,FDA-2013-E-0397,Glaukos Corporation (Knobbe Martens Olson & Bear LLP) - Patent Extension  Application,Other,Application,2013-04-05T04:00:00Z,2013,4,2013-04-05T04:00:00Z,,2013-04-05T14:29:08Z,,0,0,090000648126b8a5